Harvard Drug CEO retires, AmerisourceBergen executive steps in
DETROIT — A leading wholesale distributor of prescription and over-the-counter pharmaceuticals announced the retirement of its CEO.
Harvard Drug said that Randolph "Randy" Friedman will retire after leading the business for 23 years. Terrance Haas, an industry veteran who most recently served as AmerisourceBergen president and board member of the Healthcare Distribution Management Association will be Harvard Drug's new chief executive.
“We are thrilled to bring on Terry Haas as Harvard Drug’s new CEO,” Friedman said. “I am proud to have led Harvard Drug’s growth for the last 23 years and I am confident that our customers will continue to receive the same high-quality service that they have come to expect. With an industry veteran like Terry, Harvard Drug is well positioned to continue its strong growth and broaden its value to consumers of healthcare services across the country. I look forward to supporting Terry and the team in ensuring a smooth transition.”